VirusesBiochemistryPeer-reviewed journal article
HIV-1 Nef uses a conserved pocket to recruit the N-terminal cytoplasmic tail of Serinc3
Mohammad Karimian ShamsabadiiD, Charlotte A. StonehamiD, Amalia De-leon, Tony Fares, John Guatelli, Xiaofei JiaiD
Abstract
Human transmembrane proteins Serinc3 and Serinc5 are antiviral restriction factors that inhibit HIV-1 infectivity. In the absence of viral antagonism, Serinc3 and Serinc5 incorporate into the envelopes of nascent virions and inhibit the fusion of virions to the target cells. The HIV-1 virus counteracts the restriction of Serinc3 by downregulating it from the cell surface and thus excluding it from budding virions. This is orchestrated by the viral accessory protein Nef and involves hijacking of the clathrin adaptor protein complex 2 (AP2)-dependent endocytosis. The mechanistic details of Nef-mediated Serinc3 downregulation, however, have been enigmatic. In this work, we investigated and revealed the molecular determinants of Serinc3 modulation by Nef. Our results show that Nef recruits Serinc3 by binding to its N-terminal cytosolic tail. Furthermore, Nef residues important for Serinc3-binding in vitro, and for the exclusion of Serinc3 from virions, overlap with those required for Nef-mediated CD4 downregulation, suggesting great mechanistic similarities between the two functions of Nef. In addition to shedding light to the mechanism of Serinc3 antagonism, our work also highlights the conserved substrate-binding pocket of Nef as a molecular hotspot for inhibitor development and antiretroviral drug discovery.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: drug response / drug discovery
- approach: experimental assay
- approach: biophysical modeling
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 32th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIV-1 Nef and CycK:CDK13 antagonize SERINC5 for optimal viral infectivity
Q. Chai, S. Li, … Y.-H. Zheng·bioRxiv·May 24, 2021
- Nef enhances HIV-1 replication and infectivity independently of SERINC3 and SERINC5 in CEM T cells
P. W. Ramirez, T. Vollbrecht, … J. Guatelli·bioRxiv·Jul 15, 2020
- SERINC5 Is the Primary Target of Retroviral Antagonists Among Human SERINC Paralogs and Requires a Tri-Cysteine Motif for Its Counteraction by HIV-1 Nef
Cinzia Bertelli, Annachiara Rosa, … Massimo Pizzato·Journal of VirologyPeer-reviewed·Oct 12, 2026
- Restriction of HIV-1 infectivity by interferon and IFITM3 is counteracted by Nef
Mahesh Agarwal, Kin Kui Lai, … Alex A. Compton·Science AdvancesPeer-reviewed·Oct 1, 2025
- CryoEM Structures of the Human HIV-1 Restriction Factor SERINC3 and Function as a Lipid Transporter
S. A. Leonhardt, M. D. Purdy, … M. Yeager·bioRxiv·Jul 6, 2022
- Proteasomal degradation of human SERINC4: a potent host anti-HIV-1 factor that is antagonized by Nef
X. Qiu, I. E. Eke, … Y.-H. Zheng·bioRxiv·Dec 7, 2020